The failure rate of clinical trials for Alzheimer’s – why we need to raise our game
New research published today in Alzheimer’s Research and Therapy has shown that the failure rate for Alzheimer’s Disease drug development is 99.6%. In this guest blog, Dr Simon Ridley, Head of Research at Alzheimer’s Research UK, discusses the challenges we are facing in tackling this devastating condition, and what we can do to address them…. Read more »
4